What is the effect of GLP-1 agonists on bone and muscle in non-obese patients with normal BMI compared to obese or overweight patients?
No direct evidence for the effect of GLP-1 agonists on bone and muscle in non-obese patients with normal BMI compared to obese or overweight patients was identified. Indirect evidence suggests GLP-1 agonists may have a neutral impact on bone health while reducing muscle mass primarily through weight loss.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-28
- DOI
- https://doi.org/10.5281/zenodo.23727507
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00